OCA at 12:01, 6 March 2024

OCA — Wed, 06 Mar 2024 12:01:54 GMT

←Older revision		Revision as of 12:01, 6 March 2024
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 8asf is ~~ON HOLD~~	+	==Crystal structure of Thrombin in complex with macrocycle T1==
-		+	<StructureSection load='8asf' size='340' side='right'caption='[[8asf]], [[Resolution\|resolution]] 2.58Å' scene=''>
-	~~Authors~~: ~~Chinellato~~, M., ~~Angelini~~, A., ~~Nielsen~~, A., ~~Heinis~~, C., ~~Cendron~~, L.	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[8asf]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8ASF OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8ASF FirstGlance]. <br>
-	~~Description~~: ~~Crystal structure of~~ Thrombin in complex with ~~macrocycle T1~~	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.58Å</td></tr>
-	[[Category: ~~Unreleased Structures~~]]	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NWF:5-chloranyl-~{N}-[[(9~{S},15~{R})-8,14,17-tris(oxidanylidene)-3,20-dithia-7,13,16-triazatetracyclo[20.2.2.1^{5,7}.1^{9,13}]octacosa-1(25),22(26),23-trien-15-yl]methyl]thiophene-2-carboxamide'>NWF</scene></td></tr>
-	[[Category: ~~Chinellato, M~~]]	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8asf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8asf OCA], [https://pdbe.org/8asf PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8asf RCSB], [https://www.ebi.ac.uk/pdbsum/8asf PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8asf ProSAT]</span></td></tr>
-	[[Category: ~~Nielsen,~~ A]]	+	</table>
-	[[Category: ~~Angelini, A~~]]	+	== Disease ==
-	[[Category: Heinis, C]]	+	[https://www.uniprot.org/uniprot/THRB_HUMAN THRB_HUMAN] Defects in F2 are the cause of factor II deficiency (FA2D) [MIM:[https://omim.org/entry/613679 613679]. It is a very rare blood coagulation disorder characterized by mucocutaneous bleeding symptoms. The severity of the bleeding manifestations correlates with blood factor II levels.<ref>PMID:14962227</ref> <ref>PMID:6405779</ref> <ref>PMID:3771562</ref> <ref>PMID:3567158</ref> <ref>PMID:3801671</ref> <ref>PMID:3242619</ref> <ref>PMID:2719946</ref> <ref>PMID:1354985</ref> <ref>PMID:1421398</ref> <ref>PMID:1349838</ref> <ref>PMID:7865694</ref> <ref>PMID:7792730</ref> Genetic variations in F2 may be a cause of susceptibility to ischemic stroke (ISCHSTR) [MIM:[https://omim.org/entry/601367 601367]; also known as cerebrovascular accident or cerebral infarction. A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors.<ref>PMID:15534175</ref> Defects in F2 are the cause of thrombophilia due to thrombin defect (THPH1) [MIM:[https://omim.org/entry/188050 188050]. It is a multifactorial disorder of hemostasis characterized by abnormal platelet aggregation in response to various agents and recurrent thrombi formation. Note=A common genetic variation in the 3-prime untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increased risk of venous thrombosis. Defects in F2 are associated with susceptibility to pregnancy loss, recurrent, type 2 (RPRGL2) [MIM:[https://omim.org/entry/614390 614390]. A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions.<ref>PMID:11506076</ref>
-	[[Category: ~~Cendron, L~~]]	+	== Function ==
		+	[https://www.uniprot.org/uniprot/THRB_HUMAN THRB_HUMAN] Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing.<ref>PMID:2856554</ref>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Homo sapiens]]
		+	[[Category: Large Structures]]
		+	[[Category: Angelini A]]
		+	[[Category: Cendron L]]
		+	[[Category: Chinellato M]]
		+	[[Category: Heinis C]]
		+	[[Category: Nielsen A]]

OCA: Protected "8asf" [edit=sysop:move=sysop]

OCA — Thu, 25 Aug 2022 03:47:16 GMT

Protected "8asf" [edit=sysop:move=sysop]

←Older revision

Revision as of 03:47, 25 August 2022

OCA: New page: '''Unreleased structure''' The entry 8asf is ON HOLD Authors: Chinellato, M., Angelini, A., Nielsen, A., Heinis, C., Cendron, L. Description: Crystal structure of Thrombin in complex w...

OCA — Thu, 25 Aug 2022 03:47:15 GMT

New page: '''Unreleased structure''' The entry 8asf is ON HOLD Authors: Chinellato, M., Angelini, A., Nielsen, A., Heinis, C., Cendron, L. Description: Crystal structure of Thrombin in complex w...

New page

'''Unreleased structure'''

The entry 8asf is ON HOLD

Authors: Chinellato, M., Angelini, A., Nielsen, A., Heinis, C., Cendron, L.

Description: Crystal structure of Thrombin in complex with macrocycle T1
[[Category: Unreleased Structures]]
[[Category: Chinellato, M]]
[[Category: Nielsen, A]]
[[Category: Angelini, A]]
[[Category: Heinis, C]]
[[Category: Cendron, L]]

8asf - Revision history

OCA at 12:01, 6 March 2024

OCA: Protected "8asf" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 8asf is ON HOLD Authors: Chinellato, M., Angelini, A., Nielsen, A., Heinis, C., Cendron, L. Description: Crystal structure of Thrombin in complex w...